KTP laser

DEVICE4 trials

Sponsors

University of Helsinki, Kaplan Medical Center, Cutera Inc., Insel Gruppe AG, University Hospital Bern

Conditions

BPH (Benign Prostatic Hyperplasia)Laryngeal NeoplasmsRosaceaSpider Angioma

Phase 2

Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea

CompletedNCT06033352

Insel Gruppe AG, University Hospital BernRosacea

Start: 2023-09-12End: 2024-11-01Updated: 2024-12-06

Unknown Phase

KTP Green Light Prostatectomy Compared With TUR-P in High Risk Patients

Active, not recruitingNCT02075736

University of HelsinkiBPH (Benign Prostatic Hyperplasia)

Start: 2011-03-31End: 2025-12-31Target: 40Updated: 2024-03-06

KTP vs CO2 Laser for the Treatment of Laryngeal Carcinoma

Kaplan Medical CenterLaryngeal Neoplasms

Start: 2013-01-31End: 2020-01-31Target: 40Updated: 2016-10-11

Clinical Evaluation of the Treatment of Spider Angioma

CompletedNCT02755467

Cutera Inc.Spider Angioma

Start: 2016-05-26End: 2017-04-04Updated: 2023-03-24

Related Papers

Treatment of redness in rosacea with potassium-titanyl-phosphate (KTP) 532 nm laser with and without topical 1% ivermectin cream: a randomized split-face trial.

2026-03-04

Treatment of redness in rosacea with potassium–titanyl-phosphate (KTP) 532 nm laser with and without topical 1% ivermectin cream: a randomized split-face trial

Figshare2026-03-04

Treatment of redness in rosacea with potassium–titanyl-phosphate (KTP) 532 nm laser with and without topical 1% ivermectin cream: a randomized split-face trial

Figshare2026-03-04